Capital raising: Afterpay asks shareholders to tip in another $330 million

AfterPay Touch Group Ltd (ASX: APT) is completing a huge capital raising.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

AfterPay Touch Group Ltd (ASX: APT) shares are locked in a trading halt this morning after the buy-now-pay-later group flagged that it wants to raise $300 million via the issue of new shares to institutional investors at a minimum underwritten price of $21.75 per share. 

Retail shareholders will also be offered $30 million worth of new shares at either the lower end of the price paid by institutional investors or the 5-day volume weighted average price up until the share placement plan closes.

These shareholders will be eligible to apply for up to $15,000 worth of shares subject to a scale-back that is likely to be substantial or greater than 50% given the enthusiasm for the business and discount to the exchange traded price that could be a double-digit percentage.

Moreover, $30 million of new shares is not much for retail investors to fight over given a $5.8 billion market cap and a back of the envelope calculation shows that it would only take 2,000 retail shareholders ($30 million / $15,000) to apply for their full amount before a scale back took effect.

The maths are no secret and also likely to create a multiplier effect where a lot of retail investors apply for more shares than they actually want in the expectation of being scaled back and attempt to sell Afterpay shares on the exchange at a higher price than the placement price in order to fund the deal or simply make a small trading profit. 

As such shareholders can expect the stock to remain volatile and potentially drift lower towards the final bookbuild price due to be struck later today. 

Afterpay's leaders Anthony Eisen, Nick Molnar and David Hancock are also to sell 2.05 million, 2.05 million and 0.4 million shares respectively to U.S. institutional investors at whatever the final placement price lands at.

After the raising Afterpay will have 5.8% more shares on issue which of course means all shares on issue will be worth a smaller slice of any future profits, but importantly it will have $330.8 million cash on hand to give it the balance sheet firepower and flexibility to invest heavily for the long term, rather than worry about turning short-term profits. 

Afterpay joins a number of other popular companies to raise money on the ASX recently including WiseTech Global Ltd (ASX: WTCBravura Solutions Ltd (ASX: BVS), Audinate Ltd (ASX: AD8) and Volpara Health Technologies Ltd (ASX: VHT).

Motley Fool contributor Tom Richardson owns shares of AFTERPAY T FPO and WiseTech Global.

You can find Tom on Twitter @tommyr345

The Motley Fool Australia has recommended AUDINATEGL FPO, Bravura Solutions Ltd, and VOLPARA FPO NZ. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Share Market News

Forget Westpac shares, these ASX ETFs could be better buys

Here's why these funds could be quality picks for investors looking for alternatives to the banks.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »